Aripiprazole Tablet
Product Images NDC 70518-3090

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 70518-3090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aripiprazole-fig-16.jpg (Aripiprazole Fig 16)

FDA Label Image

Aripiprazole-fig-17 (Aripiprazole Fig 17)

FDA Label Image

Effects Of Other Drugs On Dehydro-aripiprazole (Aripiprazole Fig10)

FDA Label Image

Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig11)

FDA Label Image

Effects Of Intrinsic Factors On Aripiprazole (Aripiprazole Fig12)

FDA Label Image

Effects Of Intrinsic Factors On Dehydro-aripiprazole (Aripiprazole Fig13)

FDA Label Image

Effects Of Other Drugs On Aripiprazole (Aripiprazole Fig9)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
ARIPiprazole is a prescription drug manufactured by Ascend Labs, LLC in Montvale, NJ. It is sold in a 30-pill pack with an NDC number of 70518-3090-00 and a source NDC of 67877-0430-05. The medication should be stored at 20-26°C (63-77°F), and children should not have access to it. The package insert contains instructions for use. This particular medication was repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Aripiprazole Structure (Aripiprazole Fig8)

FDA Label Image

Aripiprazole-graph (Aripiprazole Graph)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.